Whereas the entorhinal cortex (EC) receives noradrenergic innervations from the locus coeruleus of the pons and expresses adrenergic receptors, the function of norepinephrine (NE) in the EC is still elusive. We examined the effects of NE on GABA A receptor- resulting in activation of phospholipase C (PLC) pathway, NE-mediated facilitation of GABAergic transmission was independent of PLC, protein kinase C and tyrosine kinase activities. Our results suggest that NE-mediated facilitation of GABAergic function contributes to its antiepileptic effects in the EC.
Introduction
The entorhinal cortex (EC) mediates the majority of connections between the hippocampus and other cortical areas (Witter et al. 1989 (Witter et al. , 2000 . Sensory inputs converge onto the superficial layers (layers I-III) of the EC (Burwell 2000) which give rise to dense projections to the hippocampus; the axons of the stellate neurons in layer II of the EC form the perforant path that innervates the dentate gyrus and CA3 (Steward and Scoville 1976) whereas pyramidal neurons in layer II/III provide the primary input to CA1 regions (Steward and Scoville 1976; Witter et al. 2000) . Moreover, neurons in the deep layers of the EC (layers IV-VI) relay a large portion of hippocampal output projections back to the superficial layers of the EC (Kohler 1986; Dolorfo and Amaral 1998a, 1998b; van Haeften et al. 2003) and to other cortical areas (Witter et al. 1989 ).
The EC is part of a network that is closely related to the consolidation and recall of memories (for reviews see Haist et al. 2001; Squire et al. 2004; Dolcos et al. 2005; Steffenach et al. 2005 ), Alzheimer's disease (Hyman et al. 1984; Kotzbauer et al. 2001) , schizophrenia (Falkai et al. 1988; Arnold et al. 1991; Joyal et al. 2002; Prasad et al. 2004) and temporal lobe epilepsy (Spencer and Spencer 1994) .
The EC receives innervations from the cortical mantle as well as from the brain stem. The locus coeruleus sends strong noradrenergic projections to the EC (Fallon et al. 1978; Palkovits et al. 1979; Wilcox and Unnerstall 1990) . The EC also expresses @ 1 (Stanton et al. 1987) , @ 2 (Unnerstall et al. 1984 (Unnerstall et al. , 1985 Boyajian et al. 1987) and J (Booze et al. 1993) adrenergic receptors. In accordance with the structural innervations of noradrenergic fibers and the expression of adrenergic receptors in the EC, application of norepinephrine (NE) inhibits excitatory synaptic transmission in the EC (Pralong and Magistretti 1994, Page 3 of 43 4 1995) and reduces epileptiform discharges induced by bicuculline (Stoop et al. 2000) via @ 2 receptors. Furthermore, NE has been reported to block low Mg 2+ -induced epileptiform activity via @ 1 receptors in the EC (Stanton et al. 1987) . Because bicuculline-induced epileptic model is produced by inhibition of GABAergic transmission whereas low Mg 2+ -induced epileptic model is due to an overactivation of NMDA type of glutamate receptors, these results suggest that NE modulates inhibitory and excitatory synaptic transmission via distinct adrenergic receptors. However, the effects of NE on inhibitory synaptic transmission have never been determined. In the present study, we have examined the effects of NE on GABAergic transmission in the EC. Our results indicate that NE increases GABAergic transmission in the superficial layers of the EC via activation of 1 receptors. NE-mediated increase in GABA release is independent of Ca 2+ , phospholipase C, protein kinase C and tyrosine kinase activities. NE-mediated facilitation of GABAergic function likely contributes to its antiepileptic effects in the EC.
Methods

Slice preparation
Horizontal brain slices (400 Km) including the EC, subiculum and hippocampus were cut using a vibrating blade microtome (VT1000S; Leica, Wetzlar, Germany) usually from 13-to 20-day-old Sprague Dawley rats as described previously (Deng and Lei 2006, 2007; Deng et al. 2006 Deng et al. , 2007 . After being deeply anesthetized with isoflurane, rats were decapitated and their brains were dissected out in ice-cold saline solution that contained (in mM): 130 NaCl, 24 NaHCO 3 , 3.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 , 5.0 MgCl 2 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 , pH 7.4. Slices were initially incubated in the above solution at 35 o C for 40 min for recovery and then kept at room temperature 
Recordings of spontaneous, miniature and evoked GABA A receptor-mediated IPSCs
Whole-cell patch-clamp recordings using two Multiclamp 700B amplifiers (Molecular Devices, Sunnyvale, CA) in voltage-clamp mode were made from the principal neurons in layer II/III of the EC visually identified with infrared video microscopy (BX51WI; Olympus, Tokyo, Japan) and differential interference contrast optics (Deng and Lei 2007; Deng et al. 2007 ). The recording electrodes were filled with the following solution (in mM): caesium gluconate 100, EGTA 0.6, MgCl 2 5, NaCl 8, ATP 2 Na 2, GTPNa 0.3, HEPES 40 and QX-314 1; pH 7.3. The extracellular solution contained (in mM): NaCl 130, NaHCO 3 24, KCl 3.5, NaH 2 PO 4 1.25, MgCl 2 1.5, CaCl 2 2.5 and glucose 10, saturated with 95% O 2 and 5% CO 2 ; pH 7.4. To record GABA A receptor-mediated spontaneous IPSCs (sIPSCs), the external solution was supplemented with dL-2-amino-5-phosphonovaleric acid (DL-APV) (100 KM) and 6,7-dinitroquinoxaline-2,3(1H, 4H)-dione (DNQX) (10 KM) to block NMDA and AMPA receptor-mediated responses, respectively. Under these conditions, the recorded inhibitory currents had a reversal potential of ~ -30 mV and were completely blocked by bicuculline methobromide (10 KM), confirming that they were mediated by GABA A receptors. Usually sIPSCs were recorded at a holding potential of +30 mV (Lei and McBain 2003; Deng and Lei 2006; Deng et al. 2006) . Miniature IPSCs (mIPSCs) were recorded by including TTX (1 KM) in the above external solution to block action potential-dependent responses. Evoked IPSCs were recorded from stellate and pyramidal neurons in the EC using the same internal and Ksec duration; 10-40 KA intensity) via a constant-current isolation unit (A360; World Precision Instrument, Sarasota, FL) connected to a patch electrode filled with oxygenated extracellular solution. Series resistance was rigorously monitored by the delivery of 5 mV voltage steps after each evoked current. Experiments were discontinued if the series resistance changed by >10%. Data were filtered at 2 kHz, digitized at 10 kHz and acquired on-line using pCLAMP 9 (Clampex) software (Molecular Devices). The recorded sIPSCs and mIPSCs were subsequently analyzed by Mini Analysis 6.0.1 (Synaptosoft Inc., Decatur, GA, USA). Each detected event was inspected visually to exclude obvious artifacts before analysis. The threshold for detection was set to 3 times the standard deviation of the noise as recorded in an event-free stretch of data (Clements and Beckers 1997). Mean amplitude, frequency, cumulative amplitude and frequency histograms were calculated by this program. NE and other drugs were bath applied. To avoid potential desensitization induced by repeated applications of NE, one slice was limited to only one application of NE. For the experiment involving N-methyl-Dglucamine (NMDG), the extracellular NaCl concentration was replaced by the same concentration of NMDG and HCl was used to adjust pH to 7.4. NE was applied after the action potentials or the firing activity had been stable for 5~10 min. The frequency of the action potentials or firing activity was calculated by Mini Analysis 6.0.1.
Recordings of holding current
Holding current at -55 mV was recorded from interneurons in layer III in the extracellular solution containing TTX (1 KM) to block action potential firing. The intracellular solution was the above K + -gluconate solution containing 0.2% biocytin. Because gradual dialysis of K + into cells changed the holding current, we began our recordings after waiting for ~15 min from the formation of whole-cell configuration. Holding currents at -55 mV were recorded every 3 s and then averaged per minute. We subtracted the average of the holding current recorded for the last minute prior to the application of NE from those recorded at different time points to zero the basal level of the holding current for better comparison. to derive wild-type, heterozygous and homozygous pups for experimental analysis. PCR genotyping from purified genomic DNA was performed as described previously (Kim et al. 1997; Deng et al. 2006 ).
Histological staining of interneurons
Data analysis
Data are presented as the means ± S.E.M. Concentration-response curve of NE was fit by EC 50 is the concentration of ligand producing a half-maximal response, and n is the Hill coefficient. Student's paired or unpaired t test or analysis of variance (ANOVA) was used for statistical analysis as appropriate; P values are reported throughout the text and significance was set as P<0.05. For sIPSC or mIPSC cumulative probability plots, events recorded 5 min prior to and 5 min after reaching the maximal effect of NE were selected.
Same bin size (25 ms for frequency and 2 pA for amplitude) was used to analyze data from control and NE treatment. Kolmogorov-Smirnoff test was used to assess the significance of the cumulative probability plots. N number in the text represents the cells examined.
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Chemicals
Corynanthine, yohimbine, propranolol, genistein and U73122 were purchased from TOCRIS (Ellisville, MO). Calphostin C and Ro318220 were from BIOMOL (Plymouth Meeting, PA). 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine (edelfosine) was purchased from Calbiochem (Darmstadt, Germany). NE and other chemicals were products of Sigma-Aldrich (St. Louis, MO).
Results
NE increases the frequency and amplitude of sIPSCs
Stellate and pyramidal neurons are the two major types of neurons in the superficial layers of the EC. In the present study, we identified these two types of neurons by their 
Involvement of . 1 receptors
NE possesses high potency for @ 1 and @ 2 , but has weak activity on J 1 adrenergic receptors. We next examined the roles of these receptors in the effects of NE on sIPSCs.
Application of a specific @ 1 receptor blocker, corynathine (100 KM) completely blocked the NE-induced increase in sIPSC frequency (101±7% of control, n=5, p=0.91, Fig. 2C) and amplitude (97±9% of control, n=5, p=0.64), whereas application of yohimbine (100 KM), a @ 2 receptor antagonist, or propranolol (100 KM), a J receptor antagonist had no effects on NE-induced increases in sIPSC frequency (yohimbine: 168±11% of control, n=5, p=0.003, Fig. 2D ; propranolol: 158±18% of control, n=5, p=0.018, Fig. 3A , B, C) without significantly altering the amplitude of mIPSCs (107±5% of control, n=5, p=0.22, Fig. 3D ). These results suggest that NE increases presynaptic GABA release with no effects on postsynaptic GABA A receptors. We then compared the kinetics of the averaged mIPSCs before and after the effect of NE reached maximal. NE significantly slowed the decay of mIPSCs (control: 23.3±1.6 ms, NE: 31.8±4.4 ms, n=5, p=0.04, Fig. 3E ).
Heterogeneous effects of NE on evoked IPSCs (eIPSCs)
We then examined the effects of NE on IPSCs evoked by placing a stimulation electrode locally in the EC to stimulate GABAergic inputs. Because the normal variation of eIPSC amplitude was ~10% in our recording condition, we defined that synapses showing changes in eIPSC amplitude by >15% in response to the application of NE (100 KM) as responsive synapses. Of the 18 synapses examined, 5 synapses exhibited increase (148±13% of control, n=5, p=0.023, Fig. 4A and 4D ), 6 synapse showed no change (96±3% of control, n=6, p=0.21, Fig. 4B and 4D ) and 7 synapses displayed decrease (66±4% of control, n=7, p<0.001, Fig. 4C and 4D ) in eIPSC amplitude in response to the Page 11 of 43 application of NE (100 KM). The biophysical mechanisms underlying NE-induced heterogeneity of eIPSCs may include the selective expression of @1 adrenergic receptors or other relevant release machineries at the stimulated presynaptic terminals and changes in presynaptic release pool at the active zone (see discussion). Consistent with our results, heterogeneity of NE-induced changes in eIPSCs has been observed in different neurons (Madison and Nicoll 1988; Hirono and Obata 2006; Braga et al. 2004; Bennett et al. 1998 ).
NE-induced increase in GABA release is Ca
2+
-independent mIPSCs recorded in the presence of TTX are independent of action potential and they are generated by spontaneous vesicle fusion. Whereas the result that NE still increased the frequency of mIPSCs in the presence of TTX suggests that voltage-gated Ca We next tested the possibility that NE opens a cationic conductance to increase GABA release. If so, the extracellular Na + should be the major cations to facilitate GABA release. Replacing the extracellular Na + with the same concentration of NMDG reduced remarkably IPSC frequency (47±4% of control, n=5, p<0.001, Fig. 5C ) and amplitude (69±2% of control, n=5, p<0.001). Subsequent application of TTX failed to further change IPSC frequency (105±4% of control, n=5, p=0.31, Fig. 5C ) and amplitude (111±10% of control, n=5, p=0.39). In this recording condition, application of NE (100 KM) still increased the frequency (152±10% of control, n=5, p<0.001, Fig. 5C ) without significantly altering the amplitude (103±4% of control, n=5, p=0.49) of IPSCs suggesting that NE-induced increases in GABA release are unlikely to be mediated via cationic channels.
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We finally tested whether an increase in intracellular Ca 2+ concentration was required for NE-induced increase in GABA release. Inclusion of the membrane-permeable Ca 2+ chelator, BAPTA-AM (100 KM), in the extracellular solution reduced sIPSC frequency to 54±4% of control (n=7, p<0.001, Fig. 5D ) and amplitude to 72±4% of control (n=7, p<0.001). Subsequent application of TTX (1 KM) did not significantly reduce sIPSC frequency (94±4% of control, n=7, p=0.2, Fig. 5D ) and amplitude (96±2% of control, n=7, p=0.12). In this recording condition, application of NE (100 KM) still significantly increased the frequency (150±8% of control, n=7, p<0.001, Fig. 5D ) with no effects on the amplitude (101±3% of control, n=7, p=0.65) of IPSCs. Furthermore, bath application of thapsigargin (10 KM), a potent inhibitor of sarco-endoplasmic reticulum Ca 2+ -ATPases, significantly reduced sIPSC frequency (84±5% of control, n=5, p=0.045, Fig.   5E ) and amplitude (73±4% of control, n=5, p=0.002). In the presence of thapsigargin, application of TTX (1 KM) further reduced sIPSC frequency to 65±5% of control (n=5, p=0.002, Fig. 5E ) and amplitude to 52±5% of control (n=5, p=0.005). Following application of NE (100 KM) still significantly increased the frequency (166±8%, n=5, p=0.001, Fig. 5E ) without altering the amplitude (104±7% of control, n=5, p=0.61) of IPSCs. Similarly, bath application of ryanodine (100 KM) reduced sIPSC frequency to 87±3% of control (n=5, p=0.02, Fig. 5F ) and amplitude to 81±3% of control (n=5, p=0.002). In the presence of ryanodine, application of TTX (1 KM) further reduced the frequency (63±11% of control, n=5, p=0.03, Fig. 5F ) and amplitude (66±8% of control, n=5, p=0.013). Following application of NE (100 KM) still significantly increased IPSC frequency (157±10% of control, n=5, p=0.005, Fig. 5F ) with no effects on IPSC 
NE does not modulate the excitability of the interneurons in layer III of the EC
Principal neurons in layer II/III receive GABAergic innervations from local interneurons.
We next tested whether NE changes the excitability of the interneurons by recording action potential firing and holding current (at -55 mV) from GABAergic interneurons in layer III of the EC. We identified interneurons by referring to the criteria set by Kumar and Buckmaster (2006) . Interneurons in layer III had smaller capacitance (24.6±1.6 pF, n=10), higher membrane resistance (349±28 MY, n=10) and apparent spike afterhyperpolarization amplitude (-14.7±1.2 mV, n=10). The identities of the interneurons were further confirmed by ad hoc biocytin staining of the recorded interneurons (Fig. 6D ). Application of NE (100 KM) changed neither the frequency of action potentials (96±7% of control, n=5, p=0.57, Fig. 6A, 6B ) nor the holding current recorded at -55 mV in the presence of 1 KM TTX (0.19±0.95 pA, n=5, p=0.85, Fig. 6C) suggesting that NE does not influence the excitability of the interneurons.
Because the above experiments were performed with whole-cell recordings, one could argue that the intracellular molecules required for the effects of NE might have been dialyzed out in whole-cell configuration. We therefore used cell-attached patches and recorded action potential firing. The pipettes contained the K + -gluconate internal solution and cell-attached patches were formed on interneurons in layer III. In this recording condition, bath application of NE (100 KM) still did not change the frequency of action potential firing (101±5% of control, n=7, p=0.85, Fig. 6E, F) . Together, these results suggest that NE does not influence the excitability of the interneurons in the EC. (Fig. 7C) . Together, these results indicate that PLC is unlikely to be involved in NE-mediated increase in GABA release. We also tested whether the activity of PKC was necessary for NE-induced increase in GABA release. Application of calphostin C (1 KM), a specific PKC inhibitor, significantly inhibited the basal sIPSC frequency (83±4% of control, n=5, p=0.008, Fig. 7D ) and amplitude (79±3% of control, n=5, p=0.002). In the presence of calphostin C, application of NE (100 KM) still significantly increased sIPSC frequency (170±14% of control, n=5, p=0.009, Fig. 7D) and amplitude (151±6% of control, n=5, p<0.001). We also used another specific PKC inhibitor, Ro318220. Application of Ro318220 (1 KM) significantly depressed sIPSC frequency (77±6% of control, n=7, p=0.007, Fig. 7E ) and amplitude (71±3% of control, n=7, p<0.001). However, following application of NE (100 KM) still significantly enhanced sIPSC frequency (155±11% of control, n=7, p=0.002, Fig. 7E ) and amplitude (145±12% of control, n=7, p=0.008). Together, these data suggest that the activity of PKC is unnecessary for NE-induced increase in GABA release. 
NE inhibits the excitability of principal neurons in the EC
If NE increases GABAergic transmission onto the principal neurons, it should reduce the excitability of the principal neurons in the EC. We next recorded from the principal neurons in the EC and tested the effects of NE on action potential firing. Application of NE (100 KM) significantly reduced the frequency of action potentials to 56±5% of control (n=6, p<0.001, Fig. 8 ) demonstrating that NE inhibits neuronal excitability in the EC.
Discussion
The EC receives noradrenergic projections from the locus coeruleus of the pons (Fallon et al. 1978; Palkovits et al. 1979; Wilcox and Unnerstall 1990) although the function of NE in the EC is still elusive. In the present study, we examined the effects of NE on GABAergic transmission and our results demonstrate that NE facilitates GABA release via activation of @ 1 receptors. We have also shown that NE-induced increase in GABA 
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Dependent on the brain regions, activation of adrenergic receptors modulates GABAergic transmission via at least three distinct ionic mechanisms. First, NE increases the frequency of sIPSCs with no effects on mIPSCs in CA1 pyramidal neurons of the hippocampus (Bergles et al., 1996) , the frontal cortex (Kawaguchi and Shindou 1998) and the hypothalamic paraventricular nucleus (Han et al. 2002) . The effects of NE in these brain regions are likely due to NE-induced depression of K + channels in presynaptic GABAergic interneurons (Bergles et al., 1996) . This mechanism, however, is not applicable for NE-induced facilitation of GABAergic transmission in the EC because depression of resting membrane K + channels increases action potential firing and Ca We have observed that NE slowed the decay of the averaged mIPSCs in the EC. There are two plausible explanations for NE-induced change in mIPSC kinetics. First, as our results suggest that the effects of NE are mediated via a direct interaction with the release machinery. If the action site of NE is on the fusion pore, the kinetics of mIPSCs could possibly be altered. Second, NE-induced slowness of mIPSC decay kinetics might be due to NE-mediated increases in the number of mIPSCs that overlay on the decay phase of previous mIPSCs resulting in a slowness of the decay kinetics of the averaged mIPSCs.
We have also observed that NE generates heterogeneous responses on evoked IPSCs. no responses. This may explain the results that NE had no effects on the amplitude of eIPSCs at some synapses. Third, NE-induced increase in spontaneous GABA release at many release sites resembles a condition named asynchronous release. NE-induced increases in asynchronous release may have reduced the size of the release pool at the active zone resulting in a reduction in eIPSCs (synchronous release). Whereas the heterogeneous effects of NE on eIPSCs may be generated by distinct biophysical mechanisms, our result that NE increased sIPSC frequency and amplitude in every cell examined ( Fig. 1) suggest that NE makes considerable contribution to the inhibition in the EC because sIPSCs represent a more natural transmission in vivo.
Our results demonstrate that NE increases GABA release via activation of @ 1 adrenergic receptors without the requirement of @ 2 or J receptors, consistent with the results from other synapses (Bergles et al. 1996; Bennett et al. 1998; Han et al. 2002; Braga et al. 2004; Hirono and Obata 2006; Araneda and Firestein 2006) . @ 1 receptors are coupled to G q/11 resulting in activation of PLC pathway. We have shown that the function of PLC is unnecessary for NE-mediated facilitation of GABA release because application of NE still increased GABA release in the presence of two PLC inhibitors (U73122 and edelfosine) and in PLCJ 1 knockout mice. Because a general caveat for the experiments of knockout animals is that the knockout animals can potentially produce compensatory signals, we cannot rule out this possibility for the experiments involving PLCJ 1 knockout mice although PLCJ1 is the type of PLCJ expressed in the hippocampal formation (Watanabe et al. 1998 ) and there has been no report in the literature suggesting that the PLCJ1 knockout mice generate other PLCJ isoforms to compensate the deleted PLCJ1.
Our results do not support any roles of the two downstream targets of PLC (IP 3 -mediated C, Cumulative probability of mIPSC frequency before and during the application of NE (n=5). Note that NE increased mIPSC frequency (reduction in the intervals of events). D, Cumulative probability of mIPSC amplitude before and during the application of NE (n=5). Note that NE failed to change mIPSC amplitude suggesting that NE does not block NE-induced increase in mIPSC frequency (n=5). F, Application of ryanodine (100 KM) failed to block NE-induced increase in mIPSC frequency (n=5). 
